Changes in insulin signaling pathways were characterized by examining the expression of PS473-AKT (a common and active phosphorylation site in AKT, which is the ultimate protein in the IRS/PI3K/AKT pathway) [13,12] in hypothalamus and hippocampus from the MDD patients and controls. This evidence concerns the gene INS and major depressive disorder.